Jeremy Worley is an associate research scientist in the Califano group. His broad interest is in understanding how cancer cells reprogram themselves to thrive in adverse conditions. To do so, he combines single-cell RNA sequencing, CRISPR based gene-perturbation, and computational methods for identifying the key regulators of cell-state. Ultimately, he wants to use this methodology not only to understand cancer but, more generally, the molecular biology of age-related disease.